Stemtech Statistics
Total Valuation
Stemtech has a market cap or net worth of 237,195. The enterprise value is 4.22 million.
| Market Cap | 237,195 |
| Enterprise Value | 4.22M |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Stemtech has 2.37 billion shares outstanding. The number of shares has increased by 43.07% in one year.
| Current Share Class | 2.37B |
| Shares Outstanding | 2.37B |
| Shares Change (YoY) | +43.07% |
| Shares Change (QoQ) | +52.54% |
| Owned by Insiders (%) | 1.29% |
| Owned by Institutions (%) | 0.00% |
| Float | 2.02B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| PB Ratio | -0.03 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.99 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -46.35% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 33.27% |
| Weighted Average Cost of Capital (WACC) | 20.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.71 |
| Inventory Turnover | 2.06 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.63% in the last 52 weeks. The beta is 2.52, so Stemtech's price volatility has been higher than the market average.
| Beta (5Y) | 2.52 |
| 52-Week Price Change | -99.63% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 40.15 |
| Average Volume (20 Days) | 46,768,705 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Stemtech had revenue of 2.47 million and -3.84 million in losses. Loss per share was -0.01.
| Revenue | 2.47M |
| Gross Profit | 1.94M |
| Operating Income | -2.60M |
| Pretax Income | -3.84M |
| Net Income | -3.84M |
| EBITDA | -2.43M |
| EBIT | -2.60M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 256,149 in cash and 4.98 million in debt, with a net cash position of -4.73 million or -0.00 per share.
| Cash & Cash Equivalents | 256,149 |
| Total Debt | 4.98M |
| Net Cash | -4.73M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -8.08M |
| Book Value Per Share | -0.00 |
| Working Capital | -10.46M |
Cash Flow
| Operating Cash Flow | -198,959 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 167,495 |
| Net Borrowing | 460,010 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 78.62%, with operating and profit margins of -105.14% and -155.55%.
| Gross Margin | 78.62% |
| Operating Margin | -105.14% |
| Pretax Margin | -155.55% |
| Profit Margin | -155.55% |
| EBITDA Margin | -98.37% |
| EBIT Margin | -105.14% |
| FCF Margin | n/a |
Dividends & Yields
Stemtech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.07% |
| Shareholder Yield | -43.07% |
| Earnings Yield | -1,620.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Stemtech has an Altman Z-Score of -21.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.17 |
| Piotroski F-Score | 2 |